Market Price

316.92 

2.37 0.8%

as of Dec 13 '19

52 Week Range:

228.65 344.32


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier preimplantation genetic screening, preimplantation genetic diagnosis, and screening used in IVF process; micro pipettes; IVF medical devices and systems; and PARAGARD, a contraceptive option. It markets its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Oct '08 Oct '09 Oct '10 Oct '11 Oct '12 Oct '13 Oct '14 Oct '15 Oct '16 Oct '17 Oct '18
Equity (BVPS) 31.49
33.47
34.79
40.49
45.27
50.33
55.19
55.68
55.97
63.39
65.58
growth rate 6.3% 3.9% 16.4% 11.8% 11.2% 9.7% 0.9% 0.5% 13.3% 3.5%
Earnings BIT 76.21
114.83
124.43
192.76
275.45
312.27
368.09
355.10
340.40
454.40
485.50
growth rate 50.7% 8.4% 54.9% 42.9% 13.4% 17.9% -3.5% -4.1% 33.5% 6.8%
Avg.PE 11.79
12.67
20.33
19.08
19.01
21.69
29.76
32.93
31.36
28.97
84.19
growth rate 7.5% 60.5% -6.2% -0.4% 14.1% 37.2% 10.7% -4.8% -7.6% 190.6%
ROA 2.54
3.91
4.44
6.81
8.92
9.74
7.11
4.56
6.13
7.99
2.55
growth rate 53.9% 13.6% 53.4% 31.0% 9.2% -27.0% -35.9% 34.4% 30.3% -68.1%
ROE 4.61
6.80
7.03
9.73
12.03
12.88
10.85
7.77
10.21
12.69
4.32
growth rate 47.5% 3.4% 38.4% 23.6% 7.1% -15.8% -28.4% 31.4% 24.3% -66.0%
ROIC 2.83
5.57
5.94
8.12
10.48
11.37
8.21
5.38
7.19
9.38
4.14
growth rate 96.8% 6.6% 36.7% 29.1% 8.5% -27.8% -34.5% 33.6% 30.5% -55.9%
Cur. Ratio 2.06
2.87
2.46
2.02
2.51
2.33
1.79
1.48
1.74
2.41
2.03
growth rate 39.3% -14.3% -17.9% 24.3% -7.2% -23.2% -17.3% 17.6% 38.5% -15.8%
Quick Ratio 0.63
1.00
1.01
0.82
0.94
0.96
0.68
0.53
0.73
1.02
0.84
growth rate 58.7% 1.0% -18.8% 14.6% 2.1% -29.2% -22.1% 37.7% 39.7% -17.7%
Leverage 1.83
1.66
1.51
1.35
1.34
1.30
1.73
1.67
1.66
1.53
1.85
growth rate -9.3% -9.0% -10.6% -0.7% -3.0% 33.1% -3.5% -0.6% -7.8% 20.9%
Balance Sheet Oct '08 Oct '09 Oct '10 Oct '11 Oct '12 Oct '13 Oct '14 Oct '15 Oct '16 Oct '17 Oct '18
Acct.Receivable 159.20
170.90
197.50
248.46
273.71
270.72
276.28
282.92
291.40
316.60
374.70
growth rate 7.4% 15.6% 25.8% 10.2% -1.1% 2.1% 2.4% 3.0% 8.7% 18.4%
Acct.Payable 113.37
148.14
174.10
116.35
116.91
107.40
142.10
146.40
growth rate 30.7% 17.5% -33.2% 0.5% -8.1% 32.3% 3.0%
Cur.Assets 526.00
503.90
491.30
540.35
657.86
747.24
791.62
841.43
937.10
953.20
1,090.90
growth rate -4.2% -2.5% 10.0% 21.8% 13.6% 5.9% 6.3% 11.4% 1.7% 14.5%
Total Assets 2,587.60
2,551.90
2,525.00
2,624.52
2,941.38
3,137.26
4,458.34
4,459.86
4,478.60
4,858.70
6,112.80
growth rate -1.4% -1.1% 3.9% 12.1% 6.7% 42.1% 0.0% 0.4% 8.5% 25.8%
Cash 1.90
3.90
3.60
5.18
12.84
77.39
25.22
16.43
100.80
88.80
77.70
growth rate 105.3% -7.7% 43.8% 148.1% 502.8% -67.4% -34.9% 513.7% -11.9% -12.5%
Inventory 283.50
260.80
227.90
253.58
320.20
338.92
381.47
419.69
417.70
454.10
468.80
growth rate -8.0% -12.6% 11.3% 26.3% 5.9% 12.6% 10.0% -0.5% 8.7% 3.2%
Cur.Liabilities 255.40
175.40
199.50
267.21
262.55
321.25
442.18
568.78
543.20
396.10
536.50
growth rate -31.3% 13.7% 33.9% -1.7% 22.4% 37.6% 28.6% -4.5% -27.1% 35.5%
Liabilities 1,170.50
1,011.60
858.20
687.03
748.63
732.73
1,869.90
1,785.96
1,782.70
1,682.90
2,805.00
growth rate -13.6% -15.2% -20.0% 9.0% -2.1% 155.2% -4.5% -0.2% -5.6% 66.7%
LT Debt 861.80
771.60
592.00
327.45
348.42
301.67
1,280.83
1,105.41
1,107.40
1,149.30
1,985.70
growth rate -10.5% -23.3% -44.7% 6.4% -13.4% 324.6% -13.7% 0.2% 3.8% 72.8%
Equity 1,417.10
1,540.30
1,666.80
1,937.49
2,192.75
2,404.54
2,569.88
2,667.51
2,695.80
3,175.70
3,307.60
growth rate 8.7% 8.2% 16.2% 13.2% 9.7% 6.9% 3.8% 1.1% 17.8% 4.2%
Common Shares 47.00
45.00
47.00
48.00
49.00
50.00
49.00
49.00
49.00
50.00
50.00
growth rate -4.3% 4.4% 2.1% 2.1% 2.0% -2.0% 0.0% 0.0% 2.0% 0.0%
Cash Flow Statement Oct '08 Oct '09 Oct '10 Oct '11 Oct '12 Oct '13 Oct '14 Oct '15 Oct '16 Oct '17 Oct '18
Capital Expenditures 124.90
93.90
73.80
103.67
99.78
178.13
238.07
243.00
152.60
127.20
1,299.00
growth rate -24.8% -21.4% 40.5% -3.8% 78.5% 33.7% 2.1% -37.2% -16.6% 921.2%
Cash Dividends 2.70
2.70
2.70
2.82
2.86
3.93
2.88
2.90
2.90
2.90
2.90
growth rate 0.0% 0.0% 4.3% 1.5% 37.4% -26.5% 0.6% 0.0% 0.0% 0.0%
Cash From OA 96.50
223.10
267.70
336.28
315.12
415.93
454.82
390.90
509.60
593.60
668.90
growth rate 131.2% 20.0% 25.6% -6.3% 32.0% 9.4% -14.1% 30.4% 16.5% 12.7%
FCF per Share -0.61
1.97
4.78
4.82
4.38
4.88
4.13
3.94
5.00
9.24
9.04
growth rate 100.0% 142.6% 0.8% -9.1% 11.4% -15.4% -4.6% 26.9% 84.8% -2.2%
Sale Purchase of Stock 82.04
-18.26
-152.25
8.59
19.80
20.40
10.70
growth rate -100.0% 0.0% 100.0% 130.6% 3.0% -47.6%
FCF -28.00
129.00
194.00
233.00
215.00
238.00
217.00
148.00
357.00
466.00
475.00
growth rate 100.0% 50.4% 20.1% -7.7% 10.7% -8.8% -31.8% 141.2% 30.5% 1.9%
Income Statement Oct '08 Oct '09 Oct '10 Oct '11 Oct '12 Oct '13 Oct '14 Oct '15 Oct '16 Oct '17 Oct '18
Sales 1,047.40
1,080.40
1,158.50
1,330.84
1,445.14
1,587.73
1,717.78
1,797.10
1,966.80
2,139.00
2,532.80
growth rate 3.2% 7.2% 14.9% 8.6% 9.9% 8.2% 4.6% 9.4% 8.8% 18.4%
Op.Income 127.00
149.90
189.90
158.94
246.94
296.15
368.09
355.10
340.40
454.40
485.50
growth rate 18.0% 26.7% -16.3% 55.4% 19.9% 24.3% -3.5% -4.1% 33.5% 6.8%
IBT 76.20
114.80
124.40
192.76
275.45
312.27
296.53
215.50
295.60
394.00
331.90
growth rate 50.7% 8.4% 55.0% 42.9% 13.4% -5.0% -27.3% 37.2% 33.3% -15.8%
Net Income 65.50
100.50
112.80
158.94
246.94
296.15
269.86
203.50
273.90
372.90
139.90
growth rate 53.4% 12.2% 40.9% 55.4% 19.9% -8.9% -24.6% 34.6% 36.1% -62.5%
EPS 1.43
2.21
2.43
3.63
5.05
5.96
5.51
4.14
5.59
7.52
2.81
growth rate 54.6% 10.0% 49.4% 39.1% 18.0% -7.6% -24.9% 35.0% 34.5% -62.6%
Gross Profit 610.00
596.50
676.70
804.80
924.01
1,026.81
1,108.07
1,132.60
1,177.50
1,377.30
1,681.60
growth rate -2.2% 13.5% 18.9% 14.8% 11.1% 7.9% 2.2% 4.0% 17.0% 22.1%
R&D 35.50
33.30
35.30
43.58
51.73
58.83
65.66
65.00
65.40
69.20
84.80
growth rate -6.2% 6.0% 23.5% 18.7% 13.7% 11.6% -1.0% 0.6% 5.8% 22.5%

Quarterly Statements

Item Name Jul '18 Oct '18 Jan '19 Apr '19 Jul '19
Earnings BIT 146.10
75.60
125.90
141.70
153.40
growth rate -48.3% 66.5% 12.6% 8.3%
Balance Sheet Jul '18 Oct '18 Jan '19 Apr '19 Jul '19
Acct.Receivable 375.60
374.70
389.70
396.20
404.70
growth rate -0.2% 4.0% 1.7% 2.2%
Acct.Payable 120.80
146.40
129.60
129.20
141.50
growth rate 21.2% -11.5% -0.3% 9.5%
Cur.Assets 1,188.80
1,090.90
1,193.00
1,136.60
1,150.80
growth rate -8.2% 9.4% -4.7% 1.3%
Total Assets 6,256.90
6,112.80
6,298.60
6,203.40
6,172.80
growth rate -2.3% 3.0% -1.5% -0.5%
Cash 155.60
77.70
146.60
104.60
112.70
growth rate -50.1% 88.7% -28.7% 7.7%
Inventory 479.60
468.80
486.20
493.10
502.10
growth rate -2.3% 3.7% 1.4% 1.8%
Cur.Liabilities 461.40
536.50
938.60
940.90
889.40
growth rate 16.3% 75.0% 0.3% -5.5%
Liabilities 3,030.30
2,805.00
2,873.10
2,661.20
2,557.30
growth rate -7.4% 2.4% -7.4% -3.9%
LT Debt 2,248.90
1,985.70
1,686.90
1,472.30
1,422.60
growth rate -11.7% -15.1% -12.7% -3.4%
Equity 3,226.50
3,307.60
3,425.30
3,542.00
3,615.30
growth rate 2.5% 3.6% 3.4% 2.1%
Common Shares 5.30
5.30
5.30
5.30
5.30
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jul '18 Oct '18 Jan '19 Apr '19 Jul '19
Capital Expenditures 52.30
43.40
79.20
52.70
75.40
growth rate -17.0% 82.5% -33.5% 43.1%
Cash Dividends 1.40
1.40
1.50
1.50
growth rate 0.0% 7.1% 0.0%
Cash From OA 235.20
236.60
101.80
214.80
196.70
growth rate 0.6% -57.0% 111.0% -8.4%
Sale Purchase of Stock
growth rate
FCF 182.90
193.20
22.60
162.10
121.30
growth rate 5.6% -88.3% 617.3% -25.2%
Income Statement Jul '18 Oct '18 Jan '19 Apr '19 Jul '19
Sales 660.00
651.50
628.10
654.30
679.40
growth rate -1.3% -3.6% 4.2% 3.8%
Op.Income 146.10
75.60
125.90
141.70
153.40
growth rate -48.3% 66.5% 12.6% 8.3%
IBT 90.40
112.70
93.80
128.10
127.00
growth rate 24.7% -16.8% 36.6% -0.9%
Net Income 100.80
100.70
103.20
122.40
120.10
growth rate -0.1% 2.5% 18.6% -1.9%
EPS
growth rate
Gross Profit 445.00
406.80
422.70
440.30
457.20
growth rate -8.6% 3.9% 4.2% 3.8%
R&D 22.50
22.60
21.00
21.00
21.50
growth rate 0.4% -7.1% 0.0% 2.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (53.38)

YOY Growth Grade:

C (55.95)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 32.83 35.53 22.25
EPS / Growth 13.7% 8.92 13.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 7.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 7.7% 11.5% 11.5%
Future PE 15.42 26.01 26.01
Future EPS 18.74 26.44 26.44
Value Price
MOS %
71.45
-77.5%
170.02
-46.4%
170.02
-46.4%
MOS Price 35.72 85.01 85.01
IRT 17.03 14.15 14.15

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.